Analyst Coverage
| Firm | Analyst |
|---|---|
| BERENBERG CAPITAL MARKETS | Caroline Palomeque |
| BOFA SECURITIES | Avikal Malik |
| BTIG | Thomas Shrader, PhD |
| CANTOR FITZGERALD | Charles Duncan, PhD |
| COWEN | Brendan Smith, PhD |
| EVERCORE ISI | Josh Schimmer, MD |
| GOLDMAN SACHS | Salveen Richter |
| H.C. WAINWRIGHT | Andrew Fein |
| JEFFERIES | Michael Yee |
| J.P. MORGAN | Jessica Fye |
| MORGAN STANLEY | Matthew Harrison |
| OPPENHEIMER | Jay Olson, CFA |
| RAYMOND JAMES | Danielle Brill, PharmD |
| SMBC | David Hoang, MD, PhD |
| STIFEL | Paul Matteis |
| SVB SECURITIES | Marc Goodman |
| UBS | Colin Bristow, MD |
| WEDBUSH SECURITIES | Laura Chico, PhD |
Denali Therapeutics Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Denali's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Denali Therapeutics or its management. Denali does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendation.